Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 4:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 937–960 of 992 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Insomnia Disorders Clear all

Conditions: Insomnia, Suicidal Ideation
Interventions: Behavioral Insomnia Treatment; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Insomnia
Interventions: Lemborexant, Lemborexant-matched placebo, Zolpidem tartrate, Zolpidem-matched placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 55 Years and older
Enrollment: 1,006 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 60
States / cities: Jasper, Alabama • Glendale, Arizona • Little Rock, Arkansas + 49 more

Conditions: Insomnia, Depressive Disorder, Major
Interventions: Eszopiclone, Placebo; Drug · Other
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 21 Years to 64 Years
Enrollment: 545 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004
U.S. locations: 65
States / cities: Birmingham, Alabama • Peoria, Arizona • Tucson, Arizona + 62 more

Conditions: Sleep Disorders
Interventions: Low rebound mattress toppers, High rebound mattress toppers; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Oppositional Defiant Disorder, Insomnia Chronic
Interventions: NiteCAPP SINCC; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 8 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Genital Neoplasms, Female, Insomnia, Pain, Adaptation, Psychological
Interventions: Cognitive Behavioral Therapy, Psychoeducation; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions
Interventions: Haelan 951; Dietary Supplement
Lead sponsor: Spectrum Clinical Research, LLC; Network
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Insomnia, Nocturnal Awakening, Irritability, Coping Behavior, Stress
Interventions: 5-Aminolevulinic Acid (5-ALA), Placebo; Dietary Supplement
Lead sponsor: University of Hawaii; Other
Eligibility: 40 Years to 70 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Insomnia, Obstructive Sleep Apnea
Interventions: rozerem, Placebo; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 60 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Transient Insomnia
Interventions: Gabapentin, Placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 309 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004
U.S. locations: 5
States / cities: Glendale, California • San Diego, California • Overland Park, Kansas + 1 more

Conditions: Sleep Initiation and Maintenance Disorders, Insomnia
Interventions: eplivanserin (SR46349), placebo; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 608 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Bridgewater, New York

Conditions: Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD), Insomnia
Interventions: Suvorexant, Placebo; Drug · Other
Lead sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance; Other
Eligibility: 21 Years to 65 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • Houston, Texas

Conditions: Mindfulness, Occupational Stress
Interventions: LifeXT Program; Behavioral
Lead sponsor: American Heart Association; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: Macon, Georgia • Chicago, Illinois

Conditions: Sleep Initiation and Maintenance Disorders
Interventions: Cognitive-Behavioral Therapy for Insomnia, zolpidem tartrate (Ambien), Placebo; Behavioral · Drug
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Health Personnel, Stress, Anxiety, Insomnia, Depression
Interventions: Cereset Research; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 100 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Posttraumatic Stress Disorders, Chronic Insomnia
Interventions: CBTI-PE, Hygiene-PE; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Delirium, Sleep Fragmentation
Interventions: Foam Earplugs, Noise Canceling Headphones; Device
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Sleep Deprivation, Critical Illness, Sleep-Wake Disorders, Bundle Care, Implementation Science, Delirium
Interventions: Nighttime noise & light reduction, Clustering patient-care interactions, Non-pharmacologic sleep aids, Daytime light exposure, Encourage out-of-bed activity, Medication management to support nighttime sleep; Behavioral · Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 62,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 7
States / cities: La Jolla, California • San Francisco, California • Orlando, Florida + 4 more

Conditions: Tracheostomy
Interventions: Passy Muir Valve, Tracheostomy Plug; Device
Lead sponsor: Gaylord Hospital, Inc; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Wallingford, Connecticut

Conditions: Insomnia Chronic, Oppositional Defiant Disorder
Interventions: SLEEP: COPE; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 8 Years to 12 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Insomnia Disorder, Cognitive Functioning
Interventions: CBTi: Stimulus Control Core, CBTi: Sleep Restriction Core, CBTi: Sleep Compression Core; Behavioral
Lead sponsor: Idaho State University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pocatello, Idaho

Conditions: Insomnia Chronic, Autism Spectrum Disorder
Interventions: In-Person CBT for insomnia in children with autism, Remote CBT for insomnia in children with autism, Remote sleep hygiene and related education (SHARE) for insomnia in children with autism; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 6 Years to 12 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Sleep, Insomnia, Pain, Quality of Life
Interventions: Brief Behavioral Therapy for Insomnia (BBTI); Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Burnout, Professional, Depression, Insomnia, Perceived Stress, Resilience
Interventions: Transcendental Meditation technique; Behavioral
Lead sponsor: Marie Loiselle; Other
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Maywood, Illinois

Search by objective public record fields.

A Sleep-Oriented Intervention for Suicidal Behaviors

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms

Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)

Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer

Haelan 951 for Menopause Symptoms in Peri- and Postmenopausal Women

Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood

Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)

A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia

Suvorexant for Treatment of AUD and PTSD

Are Mindfulness Programs in the Workplace Effective at Reducing Stress

Combined Behavioral/Pharmacological Therapy for Insomnia

Cereset Research for Performance Improvement in a Hospital Nursing Unit

Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)

Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones

Sleep Harmonization Via Bundled Team-Based Interventions in the ICU

Safety of the Nocturnal Passy Muir Valve and Impact on Sleep Quality at an LTACH Setting

SLEEP-COPE: Sleep Intervention for Oppositional Children

Assessing Modified CBTi in Adults With Insomnia Disorder

Targeting Insomnia in School Aged Children With Autism Spectrum Disorder

Sleep Bootcamp: A Pilot Tele-Sleep Program for Former National Football League (NFL) Players

Effects of Transcendental Meditation on Physician Burnout and Depression